Alerts will be sent to your verified email
Verify Email
INDGN
|
Indegene
|
Syngene Internation.
|
Jubilant Pharmova
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
26.35 % | 12.33 % | 7.82 % |
|
5yr Avg Net Profit Margin
|
12.84 % | 15.3 % | 6.45 % |
|
Price to Book
|
5.02 | 5.41 | 2.65 |
|
P/E
|
30.14 | 50.45 | 35.98 |
|
5yr Avg Cash Conversion Cycle
|
89.95 Days | -6453.7 Days | -39.98 Days |
|
5yr Average Interest Coverage Ratio
|
24.33 | 16.15 | 3.78 |
|
5yr Avg ROCE
|
34.13 % | 13.11 % | 8.15 % |
|
5yr Avg Operating Profit Margin
|
19.32 % | 29.04 % | 16.76 % |
|
5 yr average Debt to Equity
|
0.15 | 0.15 | 0.55 |
|
5yr CAGR Net Profit
|
22.17 % | 4.15 % | 0.08 % |
|
5yr Average Return on Assets
|
15.63 % | 7.88 % | 4.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 52.68 % | 47.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.61 % | -3.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.09 % | 17.91 % | 5.97 % |
|
Indegene
|
Syngene Internation.
|
Jubilant Pharmova
|
|---|